SCHEMBL4547669

SCHEMBL4547669

C=CCOC(=O)C(CCCCC(=O)OCC)(Cc1cc(F)c(C)c(F)c1)C(=O)OCC=C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP4Z1 Q86W10 2/20 0.33
TNF P01375 1/20 0.33
CYP4F2 P78329 2/20 0.32
CYP4A11 Q02928 2/20 0.32
PTPN1 P18031 2/20 0.32
NR1I2 O75469 1/20 0.32
PGR P06401 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
PTGS2 P35354 1/20 0.32
PDE4D Q08499 1/20 0.32
PTPRB P23467 1/20 0.31
CYP4F11 Q9HBI6 1/20 0.31
CYP4F12 Q9HCS2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676659 0.87 TSHR (0.34) TSHR
SCHEMBL2675498 0.82 TSHR (0.33) TSHR
SCHEMBL2291678 0.80 TSHR (0.39) TSHRCYP1A2ALDH1A1CYP3A4ALOX15
SCHEMBL4547661 0.77 CYP3A4 (0.31) CYP3A4
SCHEMBL2289618 0.76 TSHR (0.37) TSHRCYP1A2ALDH1A1CYP3A4TDP1
SCHEMBL8233563 0.75 TSHR (0.36) TSHRCYP1A2ALDH1A1CYP3A4ALOX15
SCHEMBL2295671 0.73 CYP4Z1 (0.39) TSHRCYP1A2CYP3A4HSD17B10TDP1
SCHEMBL2289975 0.71 CYP4Z1 (0.37) TSHRHSD17B10TDP1CYP4Z1CYP4F2
SCHEMBL7212781 0.71 TSHR (0.76) TSHRCYP1A2ALDH1A1CYP3A4ALOX15
SCHEMBL13443166 0.70 ALDH1A1 (0.51) TSHRALDH1A1TDP1PTPRBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173704-B2 Difluorophenol derivatives and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-05-08 US disclosed
US-20090291993-A1 Difluorophenol Derivatives and Their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291993-A1 Difluorophenol Derivatives and Their Use TPMT, FABP3, DPP4 TSHR 1729/4885CYP1A2 316/4885ALDH1A1 168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.